{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:30:27Z","timestamp":1787056227986,"version":"build-2736575974"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat. Rev. Neurosci."],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41583-026-01057-x","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:08:57Z","timestamp":1783328937000},"page":"597-617","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Using human 3D organoid models to gain mechanistic insight in motor neuron diseases"],"prefix":"10.1038","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8194-3796","authenticated-orcid":false,"given":"Benedetta","family":"Frizzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8463-2438","authenticated-orcid":false,"given":"Adriana Margarida","family":"Barbosa Correia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Faravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0104-4067","authenticated-orcid":false,"given":"Ludo","family":"Van Den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5425-969X","authenticated-orcid":false,"given":"Stefania","family":"Corti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1057_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00702-010-0476-6","volume":"118","author":"BK Harvey","year":"2011","unstructured":"Harvey, B. K., Richie, C. T., Hoffer, B. J. & Airavaara, M. Transgenic animal models of neurodegeneration based on human genetic studies. J. Neural Transm. 118, 27\u201345 (2011).","journal-title":"J. Neural Transm."},{"key":"1057_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41593-018-0236-8","volume":"21","author":"TM Dawson","year":"2018","unstructured":"Dawson, T. M., Golde, T. E. & Lagier-Tourenne, C. Animal models of neurodegenerative diseases. Nat. Neurosci. 21, 1370\u20131379 (2018).","journal-title":"Nat. Neurosci."},{"key":"1057_CR3","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.stem.2022.01.007","volume":"29","author":"H Okano","year":"2022","unstructured":"Okano, H. & Morimoto, S. iPSC-based disease modeling and drug discovery in cardinal neurodegenerative disorders. Cell Stem Cell 29, 189\u2013208 (2022).","journal-title":"Cell Stem Cell"},{"key":"1057_CR4","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nrn.2017.107","volume":"18","author":"E Di Lullo","year":"2017","unstructured":"Di Lullo, E. & Kriegstein, A. R. The use of brain organoids to investigate neural development and disease. Nat. Rev. Neurosci. 18, 573\u2013584 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"1057_CR5","first-page":"1265","volume":"18","author":"LF Hoffmann","year":"2022","unstructured":"Hoffmann, L. F. et al. Neural regeneration research model to be explored: SH-SY5Y human neuroblastoma cells. Neural Regen. Res. 18, 1265\u20131266 (2022).","journal-title":"Neural Regen. Res."},{"key":"1057_CR6","doi-asserted-by":"publisher","first-page":"621970","DOI":"10.3389\/fphys.2021.621970","volume":"12","author":"EA Makrygianni","year":"2021","unstructured":"Makrygianni, E. A. & Chrousos, G. P. From brain organoids to networking assembloids: implications for neuroendocrinology and stress medicine. Front. Physiol. 12, 621970 (2021).","journal-title":"Front. Physiol."},{"key":"1057_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.expneurol.2014.07.001","volume":"262","author":"L Poppe","year":"2014","unstructured":"Poppe, L., Ru\u00e9, L., Robberecht, W. & Van Den Bosch, L. Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS). Exp. Neurol. 262, 138\u2013151 (2014).","journal-title":"Exp. Neurol."},{"key":"1057_CR8","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/nrd3577","volume":"10","author":"M Grskovic","year":"2011","unstructured":"Grskovic, M., Javaherian, A., Strulovici, B. & Daley, G. Q. Induced pluripotent stem cells \u2014 opportunities for disease modelling and drug discovery. Nat. Rev. Drug Discov. 10, 915\u2013929 (2011).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1057_CR9","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663\u2013676 (2006).","journal-title":"Cell"},{"key":"1057_CR10","first-page":"63","volume":"9","author":"L Ye","year":"2013","unstructured":"Ye, L., Swingen, C. & Zhang, J. Induced pluripotent stem cells and their potential for basic and clinical sciences. Curr. Cardiol. Rev. 9, 63\u201372 (2013).","journal-title":"Curr. Cardiol. Rev."},{"key":"1057_CR11","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.3390\/cells8111438","volume":"8","author":"G Costamagna","year":"2019","unstructured":"Costamagna, G., Andreoli, L., Corti, S. & Faravelli, I. iPSCs-based neural 3D systems: a multidimensional approach for disease modeling and drug discovery. Cells 8, 1438 (2019).","journal-title":"Cells"},{"key":"1057_CR12","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.reth.2020.11.006","volume":"15","author":"V Valadez-Barba","year":"2020","unstructured":"Valadez-Barba, V. et al. iPSC for modeling neurodegenerative disorders. Regen. Ther. 15, 332\u2013339 (2020).","journal-title":"Regen. Ther."},{"key":"1057_CR13","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1038\/s41591-018-0140-5","volume":"24","author":"K Fujimori","year":"2018","unstructured":"Fujimori, K. et al. Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat. Med. 24, 1579\u20131589 (2018).","journal-title":"Nat. Med."},{"key":"1057_CR14","doi-asserted-by":"publisher","first-page":"e106177","DOI":"10.15252\/embj.2020106177","volume":"40","author":"R Fazal","year":"2021","unstructured":"Fazal, R. et al. HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 40, e106177 (2021).","journal-title":"EMBO J."},{"key":"1057_CR15","doi-asserted-by":"publisher","first-page":"20220040","DOI":"10.1098\/rsfs.2022.0040","volume":"12","author":"A Bhargava","year":"2022","unstructured":"Bhargava, A., Sandoval Castellanos, A. M., Shah, S. & Ning, K. An insight into the iPSCs-derived two-dimensional culture and three-dimensional organoid models for neurodegenerative disorders. Interface Focus 12, 20220040 (2022).","journal-title":"Interface Focus"},{"key":"1057_CR16","doi-asserted-by":"publisher","first-page":"1247125","DOI":"10.1126\/science.1247125","volume":"345","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A. & Knoblich, J. A. Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345, 1247125 (2014).","journal-title":"Science"},{"key":"1057_CR17","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s41593-020-00730-3","volume":"23","author":"I Chiaradia","year":"2020","unstructured":"Chiaradia, I. & Lancaster, M. A. Brain organoids for the study of human neurobiology at the interface of in vitro and in vivo. Nat. Neurosci. 23, 1496\u20131508 (2020).","journal-title":"Nat. Neurosci."},{"key":"1057_CR18","doi-asserted-by":"publisher","first-page":"dev166074","DOI":"10.1242\/dev.166074","volume":"146","author":"X Qian","year":"2019","unstructured":"Qian, X., Song, H. & Ming, G.-L. Brain organoids: advances, applications and challenges. Development 146, dev166074 (2019).","journal-title":"Development"},{"key":"1057_CR19","doi-asserted-by":"publisher","first-page":"631548","DOI":"10.3389\/fncel.2021.631548","volume":"15","author":"MR Shaker","year":"2021","unstructured":"Shaker, M. R. et al. Rapid and efficient generation of myelinating human oligodendrocytes in organoids. Front. Cell. Neurosci. 15, 631548 (2021).","journal-title":"Front. Cell. Neurosci."},{"key":"1057_CR20","doi-asserted-by":"publisher","DOI":"10.1101\/2024.08.29.610410","author":"N Kee","year":"2024","unstructured":"Kee, N. et al. Posterior specification of multi-lineage axial assembloids from human pluripotent stem cells. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.08.29.610410 (2024).","journal-title":"bioRxiv"},{"key":"1057_CR21","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1093\/brain\/awac475","volume":"146","author":"J Van Lent","year":"2023","unstructured":"Van Lent, J. et al. Downregulation of PMP22 ameliorates myelin defects in iPSC-derived human organoid cultures of CMT1A. Brain 146, 2885\u20132896 (2023).","journal-title":"Brain"},{"key":"1057_CR22","doi-asserted-by":"publisher","first-page":"748849","DOI":"10.3389\/fncel.2021.748849","volume":"15","author":"D Marangon","year":"2021","unstructured":"Marangon, D. et al. Novel in vitro experimental approaches to study myelination and remyelination in the central nervous system. Front. Cell Neurosci. 15, 748849 (2021).","journal-title":"Front. Cell Neurosci."},{"key":"1057_CR23","doi-asserted-by":"publisher","first-page":"102229","DOI":"10.1016\/j.gde.2024.102229","volume":"87","author":"A Nebol","year":"2024","unstructured":"Nebol, A. & Gouti, M. A new era in neuromuscular junction research: current advances in self-organized and assembled in vitro models. Curr. Opin. Genet. Dev. 87, 102229 (2024).","journal-title":"Curr. Opin. Genet. Dev."},{"key":"1057_CR24","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.stem.2019.12.007","volume":"26","author":"J-M Faustino Martins","year":"2020","unstructured":"Faustino Martins, J.-M. et al. Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell 26, 172\u2013186.e6 (2020). This landmark study established a self-organizing NMO model derived from NMPs, integrating spinal cord, skeletal muscle and functional NMJ-like structures to recapitulate thoracolumbar axial identity and neuromuscular connectivity.","journal-title":"Cell Stem Cell"},{"key":"1057_CR25","doi-asserted-by":"publisher","first-page":"12046","DOI":"10.3390\/ijms241512046","volume":"24","author":"O Urz\u00ec","year":"2023","unstructured":"Urz\u00ec, O. et al. Three-dimensional cell cultures: the bridge between in vitro and in vivo models. Int. J. Mol. Sci. 24, 12046 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1057_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tcb.2019.11.004","volume":"30","author":"RM Marton","year":"2020","unstructured":"Marton, R. M. & Pa\u0219ca, S. P. Organoid and assembloid technologies for investigating cellular crosstalk in human brain development and disease. Trends Cell Biol. 30, 133\u2013143 (2020).","journal-title":"Trends Cell Biol."},{"key":"1057_CR27","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/s41587-020-00763-w","volume":"38","author":"Y Miura","year":"2020","unstructured":"Miura, Y. et al. Generation of human striatal organoids and cortico-striatal assembloids from human pluripotent stem cells. Nat. Biotechnol. 38, 1421\u20131430 (2020).","journal-title":"Nat. Biotechnol."},{"key":"1057_CR28","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature20413","volume":"539","author":"JP Taylor","year":"2016","unstructured":"Taylor, J. P., Brown, R. H. & Cleveland, D. W. Decoding ALS: from genes to mechanism. Nature 539, 197\u2013206 (2016).","journal-title":"Nature"},{"key":"1057_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/s41582-020-00411-6","volume":"16","author":"I Faravelli","year":"2020","unstructured":"Faravelli, I. & Corti, S. Spinal muscular atrophy \u2014 challenges in the therapeutic era. Nat. Rev. Neurol. 16, 655\u2013656 (2020).","journal-title":"Nat. Rev. Neurol."},{"key":"1057_CR30","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-genom-102319-103602","volume":"21","author":"B Wirth","year":"2020","unstructured":"Wirth, B., Karakaya, M., Kye, M. J. & Mendoza-Ferreira, N. Twenty-five years of spinal muscular atrophy research: from phenotype to genotype to therapy, and what comes next. Annu. Rev. Genomics Hum. Genet. 21, 231\u2013261 (2020).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"1057_CR31","doi-asserted-by":"publisher","first-page":"17071","DOI":"10.1038\/nrdp.2017.71","volume":"3","author":"O Hardiman","year":"2017","unstructured":"Hardiman, O. et al. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers 3, 17071 (2017).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1057_CR32","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1056\/NEJMra1603471","volume":"377","author":"RH Brown","year":"2017","unstructured":"Brown, R. H. & Al-Chalabi, A. Amyotrophic lateral sclerosis. N. Engl. J. Med. 377, 162\u2013172 (2017).","journal-title":"N. Engl. J. Med."},{"key":"1057_CR33","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3390\/ijms24032247","volume":"24","author":"I Faravelli","year":"2023","unstructured":"Faravelli, I., Riboldi, G. M., Rinchetti, P. & Lotti, F. The SMN complex at the crossroad between RNA metabolism and neurodegeneration. Int. J. Mol. Sci. 24, 2247 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"1057_CR34","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/j.ncl.2015.07.004","volume":"33","author":"SJ Kolb","year":"2015","unstructured":"Kolb, S. J. & Kissel, J. T. Spinal muscular atrophy. Neurol. Clin. 33, 831\u2013846 (2015).","journal-title":"Neurol. Clin."},{"key":"1057_CR35","doi-asserted-by":"publisher","first-page":"S29.005","DOI":"10.1212\/WNL.90.15_supplement.S29.005","volume":"90","author":"F Rizzo","year":"2018","unstructured":"Rizzo, F. et al. A subset of axonal and synaptic genes with altered expression\/splicing in SMA-MNs harbours a common motif that interacts with SMN\/SYNCRIP complex (S29.005). Neurology 90, S29.005 (2018).","journal-title":"Neurology"},{"key":"1057_CR36","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.stem.2015.08.003","volume":"17","author":"S-Y Ng","year":"2015","unstructured":"Ng, S.-Y. et al. Genome-wide RNA-seq of human motor neurons implicates selective ER stress activation in spinal muscular atrophy. Cell Stem Cell 17, 569\u2013584 (2015).","journal-title":"Cell Stem Cell"},{"key":"1057_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2147\/TACG.S239603","volume":"14","author":"MC Keinath","year":"2021","unstructured":"Keinath, M. C., Prior, D. E. & Prior, T. W. Spinal muscular atrophy: mutations, testing, and clinical relevance. Appl. Clin. Genet. 14, 11\u201325 (2021).","journal-title":"Appl. Clin. Genet."},{"key":"1057_CR38","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1242\/dmm.030148","volume":"10","author":"M Bowerman","year":"2017","unstructured":"Bowerman, M. et al. Therapeutic strategies for spinal muscular atrophy: SMN and beyond. Dis. Model. Mech. 10, 943\u2013954 (2017).","journal-title":"Dis. Model. Mech."},{"key":"1057_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00911-y","volume":"8","author":"W Guo","year":"2017","unstructured":"Guo, W. et al. HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat. Commun. 8, 861 (2017).","journal-title":"Nat. Commun."},{"key":"1057_CR40","doi-asserted-by":"publisher","first-page":"eabg3013","DOI":"10.1126\/sciadv.abg3013","volume":"7","author":"L Fumagalli","year":"2021","unstructured":"Fumagalli, L. et al. C9orf72-derived arginine-containing dipeptide repeats associate with axonal transport machinery and impede microtubule-based motility. Sci. Adv. 7, eabg3013 (2021).","journal-title":"Sci. Adv."},{"key":"1057_CR41","doi-asserted-by":"publisher","first-page":"3306","DOI":"10.1080\/15548627.2021.1872189","volume":"17","author":"J Beckers","year":"2021","unstructured":"Beckers, J., Tharkeshwar, A. K. & Van Damme, P. C9orf72 ALS-FTD: recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Autophagy 17, 3306\u20133322 (2021).","journal-title":"Autophagy"},{"key":"1057_CR42","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.abq5622","volume":"379","author":"MW Baughn","year":"2023","unstructured":"Baughn, M. W. et al. Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies. Science 379, 1140\u20131149 (2023).","journal-title":"Science"},{"key":"1057_CR43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/s41586-022-04436-3","volume":"603","author":"A-L Brown","year":"2022","unstructured":"Brown, A.-L. et al. TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13A. Nature 603, 131\u2013137 (2022).","journal-title":"Nature"},{"key":"1057_CR44","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41583-021-00431-1","volume":"22","author":"P Tziortzouda","year":"2021","unstructured":"Tziortzouda, P., Van Den Bosch, L. & Hirth, F. Triad of TDP43 control in neurodegeneration: autoregulation, localization and aggregation. Nat. Rev. Neurosci. 22, 197\u2013208 (2021).","journal-title":"Nat. Rev. Neurosci."},{"key":"1057_CR45","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1093\/brain\/awr193","volume":"134","author":"L Ferraiuolo","year":"2011","unstructured":"Ferraiuolo, L. et al. Dysregulation of astrocyte\u2013motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis. Brain 134, 2627\u20132641 (2011).","journal-title":"Brain"},{"key":"1057_CR46","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.expneurol.2014.05.015","volume":"262","author":"T Philips","year":"2014","unstructured":"Philips, T. & Rothstein, J. D. Glial cells in amyotrophic lateral sclerosis. Exp. Neurol. 262, 111\u2013120 (2014).","journal-title":"Exp. Neurol."},{"key":"1057_CR47","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/j.immuni.2017.06.006","volume":"46","author":"SA Liddelow","year":"2017","unstructured":"Liddelow, S. A. & Barres, B. A. Reactive astrocytes: production, function, and therapeutic potential. Immunity 46, 957\u2013967 (2017).","journal-title":"Immunity"},{"key":"1057_CR48","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.ebiom.2019.11.026","volume":"50","author":"A Birger","year":"2019","unstructured":"Birger, A. et al. Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine 50, 274\u2013289 (2019).","journal-title":"EBioMedicine"},{"key":"1057_CR49","doi-asserted-by":"publisher","first-page":"1047540","DOI":"10.3389\/fmmed.2023.1047540","volume":"3","author":"K Stoklund Dittlau","year":"2023","unstructured":"Stoklund Dittlau, K. & Van Den Bosch, L. Why should we care about astrocytes in a motor neuron disease? Front. Mol. Med. 3, 1047540 (2023).","journal-title":"Front. Mol. Med."},{"key":"1057_CR50","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/j.bbadis.2006.05.002","volume":"1762","author":"L Van Den Bosch","year":"2006","unstructured":"Van Den Bosch, L., Van Damme, P., Bogaert, E. & Robberecht, W. The role of excitotoxicity in the pathogenesis of amyotrophic lateral sclerosis. Biochim. Biophys. Acta Mol. Basis Dis. 1762, 1068\u20131082 (2006).","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1057_CR51","doi-asserted-by":"publisher","first-page":"102495","DOI":"10.1016\/j.eclinm.2024.102495","volume":"69","author":"M Wiesenfarth","year":"2024","unstructured":"Wiesenfarth, M. et al. Effects of tofersen treatment in patients with SOD1-ALS in a \u201creal-world\u201d setting \u2014 a 12-month multicenter cohort study from the German early access program. eClinicalMedicine 69, 102495 (2024).","journal-title":"eClinicalMedicine"},{"key":"1057_CR52","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/nrneurol.2013.203","volume":"9","author":"A Al-Chalabi","year":"2013","unstructured":"Al-Chalabi, A. & Hardiman, O. The epidemiology of ALS: a conspiracy of genes, environment and time. Nat. Rev. Neurol. 9, 617\u2013628 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"1057_CR53","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ejmg.2017.12.001","volume":"61","author":"M Bowerman","year":"2018","unstructured":"Bowerman, M. et al. Pathogenic commonalities between spinal muscular atrophy and amyotrophic lateral sclerosis: converging roads to therapeutic development. Eur. J. Med. Genet. 61, 685\u2013698 (2018).","journal-title":"Eur. J. Med. Genet."},{"key":"1057_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3389\/fnana.2016.00006","volume":"10","author":"M Boido","year":"2016","unstructured":"Boido, M. & Vercelli, A. Neuromuscular junctions as key contributors and therapeutic targets in spinal muscular atrophy. Front. Neuroanat. 10, 6 (2016).","journal-title":"Front. Neuroanat."},{"key":"1057_CR55","doi-asserted-by":"publisher","first-page":"104870","DOI":"10.1016\/j.nbd.2020.104870","volume":"140","author":"E Abati","year":"2020","unstructured":"Abati, E., Citterio, G., Bresolin, N., Comi, G. P. & Corti, S. Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease? Neurobiol. Dis. 140, 104870 (2020).","journal-title":"Neurobiol. Dis."},{"key":"1057_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/35049541","volume":"1","author":"TM Jessell","year":"2000","unstructured":"Jessell, T. M. Neuronal specification in the spinal cord: inductive signals and transcriptional codes. Nat. Rev. Genet. 1, 20\u201329 (2000).","journal-title":"Nat. Rev. Genet."},{"key":"1057_CR57","doi-asserted-by":"publisher","first-page":"2640","DOI":"10.4161\/cc.6.21.4822","volume":"6","author":"F Ulloa","year":"2007","unstructured":"Ulloa, F. & Briscoe, J. Morphogens and the control of cell proliferation and patterning in the spinal cord. Cell Cycle 6, 2640\u20132649 (2007).","journal-title":"Cell Cycle"},{"key":"1057_CR58","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/0092-8674(91)90247-V","volume":"64","author":"T Yamada","year":"1991","unstructured":"Yamada, T., Placzek, M., Tanaka, H., Dodd, J. & Jessell, T. M. Control of cell pattern in the developing nervous system: polarizing activity of the floor plate and notochord. Cell 64, 635\u2013647 (1991).","journal-title":"Cell"},{"key":"1057_CR59","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/s41583-025-00906-5","volume":"26","author":"M Saade","year":"2025","unstructured":"Saade, M. & Marti, E. Early spinal cord development: from neural tube formation to neurogenesis. Nat. Rev. Neurosci. 26, 195\u2013213 (2025).","journal-title":"Nat. Rev. Neurosci."},{"key":"1057_CR60","doi-asserted-by":"publisher","first-page":"e52728","DOI":"10.15252\/embr.202152728","volume":"22","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Single-cell analysis reveals dynamic changes of neural cells in developing human spinal cord. EMBO Rep. 22, e52728 (2021).","journal-title":"EMBO Rep."},{"key":"1057_CR61","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/s41593-023-01312-9","volume":"26","author":"X Li","year":"2023","unstructured":"Li, X. et al. Profiling spatiotemporal gene expression of the developing human spinal cord and implications for ependymoma origin. Nat. Neurosci. 26, 891\u2013901 (2023).","journal-title":"Nat. Neurosci."},{"key":"1057_CR62","doi-asserted-by":"publisher","first-page":"a020537","DOI":"10.1101\/cshperspect.a020537","volume":"7","author":"F Ginhoux","year":"2015","unstructured":"Ginhoux, F. & Prinz, M. Origin of microglia: current concepts and past controversies. Cold Spring Harb. Perspect. Biol. 7, a020537 (2015).","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"1057_CR63","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.3389\/fimmu.2018.01014","volume":"9","author":"DA Menassa","year":"2018","unstructured":"Menassa, D. A. & Gomez-Nicola, D. Microglial dynamics during human brain development. Front. Immunol. 9, 1014 (2018).","journal-title":"Front. Immunol."},{"key":"1057_CR64","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3340\/jkns.2020.0359","volume":"64","author":"MR Shaker","year":"2021","unstructured":"Shaker, M. R., Lee, J.-H. & Sun, W. Embryonal neuromesodermal progenitors for caudal central nervous system and tissue development. J. Korean Neurosurg. Soc. 64, 359\u2013366 (2021).","journal-title":"J. Korean Neurosurg. Soc."},{"key":"1057_CR65","doi-asserted-by":"publisher","first-page":"e1001937","DOI":"10.1371\/journal.pbio.1001937","volume":"12","author":"M Gouti","year":"2014","unstructured":"Gouti, M. et al. In vitro generation of neuromesodermal progenitors reveals distinct roles for wnt signalling in the specification of spinal cord and paraxial mesoderm identity. PLoS Biol. 12, e1001937 (2014). This foundational study established the in vitro generation of bona fide NMPs from pluripotent stem cells, recapitulating key in vivo NMP features, including SOX2 and Brachyury co-expression and spinal cord\u2013paraxial mesoderm bipotency, thereby laying the groundwork for thoracolumbar neuromuscular modelling in vitro.","journal-title":"PLoS Biol."},{"key":"1057_CR66","doi-asserted-by":"publisher","first-page":"607516","DOI":"10.3389\/fcell.2020.607516","volume":"8","author":"R Sambasivan","year":"2021","unstructured":"Sambasivan, R. & Steventon, B. Neuromesodermal progenitors: a basis for robust axial patterning in development and evolution. Front. Cell Dev. Biol. 8, 607516 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1057_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.devcel.2009.08.002","volume":"17","author":"E Tzouanacou","year":"2009","unstructured":"Tzouanacou, E., Wegener, A., Wymeersch, F. J., Wilson, V. & Nicolas, J. F. Redefining the progression of lineage segregations during mammalian embryogenesis by clonal analysis. Dev. Cell 17, 365\u2013376 (2009).","journal-title":"Dev. Cell"},{"key":"1057_CR68","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.3390\/life13061254","volume":"13","author":"F Buchner","year":"2023","unstructured":"Buchner, F., Dokuzluoglu, Z., Grass, T. & Rodriguez-Muela, N. Spinal cord organoids to study motor neuron development and disease. Life 13, 1254 (2023).","journal-title":"Life"},{"key":"1057_CR69","unstructured":"Hor, J.-H. & Ng, S.-Y. in Methods Cell Biol Vol. 159 Human Pluripotent Stem Cell Derived Organoid Models (ed Spence, J. R.) 257\u2013277 (Academic, 2020)."},{"key":"1057_CR70","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.devcel.2017.04.002","volume":"41","author":"M Gouti","year":"2017","unstructured":"Gouti, M. et al. A gene regulatory network balances neural and mesoderm specification during vertebrate trunk development. Dev. Cell 41, 243\u2013261.e7 (2017).","journal-title":"Dev. Cell"},{"key":"1057_CR71","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fnmol.2015.00025","volume":"8","author":"DC Lu","year":"2015","unstructured":"Lu, D. C., Niu, T. & Alaynick, W. A. Molecular and cellular development of spinal cord locomotor circuitry. Front. Mol. Neurosci. 8, 25 (2015).","journal-title":"Front. Mol. Neurosci."},{"key":"1057_CR72","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41593-023-01311-w","volume":"26","author":"J Andersen","year":"2023","unstructured":"Andersen, J. et al. Single-cell transcriptomic landscape of the developing human spinal cord. Nat. Neurosci. 26, 902\u2013914 (2023).","journal-title":"Nat. Neurosci."},{"key":"1057_CR73","doi-asserted-by":"publisher","first-page":"4425","DOI":"10.1093\/brain\/awad202","volume":"146","author":"JM Shefner","year":"2023","unstructured":"Shefner, J. M. et al. Skeletal muscle in amyotrophic lateral sclerosis. Brain 146, 4425\u20134436 (2023).","journal-title":"Brain"},{"key":"1057_CR74","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-024-02794-y","volume":"148","author":"M Zufir\u00eda","year":"2024","unstructured":"Zufir\u00eda, M. et al. Dysregulated FOXO1 activity drives skeletal muscle intrinsic dysfunction in amyotrophic lateral sclerosis. Acta Neuropathol. 148, 43 (2024).","journal-title":"Acta Neuropathol."},{"key":"1057_CR75","doi-asserted-by":"publisher","DOI":"10.1101\/2024.09.18.613669","author":"G Picchiarelli","year":"2024","unstructured":"Picchiarelli, G. et al. FUS controls muscle differentiation and structure through LLPS mediated recruitment of MEF2 and ETV5. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.09.18.613669 (2024).","journal-title":"bioRxiv"},{"key":"1057_CR76","doi-asserted-by":"publisher","first-page":"e0205589","DOI":"10.1371\/journal.pone.0205589","volume":"13","author":"N Hellbach","year":"2018","unstructured":"Hellbach, N. et al. Impaired myogenic development, differentiation and function in hESC-derived SMA myoblasts and myotubes. PLoS One 13, e0205589 (2018).","journal-title":"PLoS One"},{"key":"1057_CR77","doi-asserted-by":"publisher","first-page":"e202201457","DOI":"10.26508\/lsa.202201457","volume":"6","author":"A Ikenaka","year":"2023","unstructured":"Ikenaka, A. et al. SMN promotes mitochondrial metabolic maturation during myogenesis by regulating the MYOD-miRNA axis. Life Sci. Alliance 6, e202201457 (2023).","journal-title":"Life Sci. Alliance"},{"key":"1057_CR78","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1038\/s41593-019-0498-9","volume":"22","author":"G Picchiarelli","year":"2019","unstructured":"Picchiarelli, G. et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci. 22, 1793\u20131805 (2019).","journal-title":"Nat. Neurosci."},{"key":"1057_CR79","doi-asserted-by":"publisher","first-page":"5108","DOI":"10.3390\/ijms23095108","volume":"23","author":"M-K Shin","year":"2022","unstructured":"Shin, M.-K. et al. Generation of skeletal muscle organoids from human pluripotent stem cells to model myogenesis and muscle regeneration. Int. J. Mol. Sci. 23, 5108 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"1057_CR80","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1016\/j.cell.2020.11.017","volume":"183","author":"J Andersen","year":"2020","unstructured":"Andersen, J. et al. Generation of functional human 3D cortico-motor assembloids. Cell 183, 1913\u20131929.e26 (2020). This pioneering study established the first functional human cortico-motor assembloid model by integrating cortical organoids with spinal cord and skeletal muscle spheroids, demonstrating long-range corticospinal connectivity and optogenetically evoked muscle contractions in a human stem cell-derived system.","journal-title":"Cell"},{"key":"1057_CR81","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.celrep.2018.03.091","volume":"23","author":"SM Maffioletti","year":"2018","unstructured":"Maffioletti, S. M. et al. Three-dimensional human iPSC-derived artificial skeletal muscles model muscular dystrophies and enable multilineage tissue engineering. Cell Rep. 23, 899\u2013908 (2018). This study generated human skeletal muscle organoids containing a long-term sustainable PAX7-positive satellite cell niche, closely modelling muscle stem cell maintenance and regenerative dynamics in vitro.","journal-title":"Cell Rep."},{"key":"1057_CR82","doi-asserted-by":"publisher","first-page":"RP87081","DOI":"10.7554\/eLife.87081","volume":"12","author":"L Mavrommatis","year":"2023","unstructured":"Mavrommatis, L. et al. Human skeletal muscle organoids model fetal myogenesis and sustain uncommitted PAX7 myogenic progenitors. eLife 12, RP87081 (2023).","journal-title":"eLife"},{"key":"1057_CR83","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02636-4","volume":"9","author":"L Rao","year":"2018","unstructured":"Rao, L., Qian, Y., Khodabukus, A., Ribar, T. & Bursac, N. Engineering human pluripotent stem cells into a functional skeletal muscle tissue. Nat. Commun. 9, 126 (2018). This study engineered human pluripotent stem cells into aligned and contractile skeletal muscle tissues using anchored 3D culture systems that generate uniaxial tension, promoting myofibre organization and functional maturation in vitro.","journal-title":"Nat. Commun."},{"key":"1057_CR84","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.ceb.2021.06.004","volume":"73","author":"S Jalal","year":"2021","unstructured":"Jalal, S., Dastidar, S. & Tedesco, F. S. Advanced models of human skeletal muscle differentiation, development and disease: three-dimensional cultures, organoids and beyond. Curr. Opin. Cell Biol. 73, 92\u2013104 (2021).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1057_CR85","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1016\/j.stemcr.2023.08.014","volume":"18","author":"E van der Wal","year":"2023","unstructured":"van der Wal, E. et al. Highly contractile 3D tissue engineered skeletal muscles from human iPSCs reveal similarities with primary myoblast-derived tissues. Stem Cell Rep. 18, 1954\u20131971 (2023).","journal-title":"Stem Cell Rep."},{"key":"1057_CR86","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1242\/dev.151035","volume":"144","author":"J Chal","year":"2017","unstructured":"Chal, J. & Pourquie, O. Making muscle: skeletal myogenesis in vivo and in vitro. Development 144, 2104\u20132122 (2017).","journal-title":"Development"},{"key":"1057_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06684-2","volume":"9","author":"PR Ormel","year":"2018","unstructured":"Ormel, P. R. et al. Microglia innately develop within cerebral organoids. Nat. Commun. 9, 4167 (2018).","journal-title":"Nat. Commun."},{"key":"1057_CR88","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/nature12517","volume":"501","author":"MA Lancaster","year":"2013","unstructured":"Lancaster, M. A. et al. Cerebral organoids model human brain development and microcephaly. Nature 501, 373\u2013379 (2013). This pioneering study established the first human cerebral organoid model by demonstrating the self-organization of pluripotent stem cells into complex brain-like structures, transforming the study of human neurodevelopment and disease.","journal-title":"Nature"},{"key":"1057_CR89","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1038\/s41591-020-1043-9","volume":"26","author":"TA Khan","year":"2020","unstructured":"Khan, T. A. et al. Neuronal defects in a human cellular model of 22q11.2 deletion syndrome. Nat. Med. 26, 1888\u20131898 (2020).","journal-title":"Nat. Med."},{"key":"1057_CR90","doi-asserted-by":"publisher","first-page":"7789","DOI":"10.1007\/s12035-016-0274-8","volume":"54","author":"H Choi","year":"2017","unstructured":"Choi, H., Song, J., Park, G. & Kim, J. Modeling of autism using organoid technology. Mol. Neurobiol. 54, 7789\u20137795 (2017).","journal-title":"Mol. Neurobiol."},{"key":"1057_CR91","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cell.2015.06.034","volume":"162","author":"J Mariani","year":"2015","unstructured":"Mariani, J. et al. FOXG1-dependent dysregulation of GABA\/glutamate neuron differentiation in autism spectrum disorders. Cell 162, 375\u2013390 (2015).","journal-title":"Cell"},{"key":"1057_CR92","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.3415","volume":"12","author":"AM Pa\u015fca","year":"2015","unstructured":"Pa\u015fca, A. M. et al. Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat. Methods 12, 671\u2013678 (2015).","journal-title":"Nat. Methods"},{"key":"1057_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9896","volume":"6","author":"H Sakaguchi","year":"2015","unstructured":"Sakaguchi, H. et al. Generation of functional hippocampal neurons from self-organizing human embryonic stem cell-derived dorsomedial telencephalic tissue. Nat. Commun. 6, 8896 (2015).","journal-title":"Nat. Commun."},{"key":"1057_CR94","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1038\/s41593-018-0175-4","volume":"21","author":"J Park","year":"2018","unstructured":"Park, J. et al. A 3D human triculture system modeling neurodegeneration and neuroinflammation in alzheimer\u2019s disease. Nat. Neurosci. 21, 941\u2013951 (2018).","journal-title":"Nat. Neurosci."},{"key":"1057_CR95","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-019-0078-4","volume":"5","author":"LM Smits","year":"2019","unstructured":"Smits, L. M. et al. Modeling parkinson\u2019s disease in midbrain-like organoids. NPJ Parkinsons Dis. 5, 5 (2019).","journal-title":"NPJ Parkinsons Dis."},{"key":"1057_CR96","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.stem.2016.07.005","volume":"19","author":"J Jo","year":"2016","unstructured":"Jo, J. et al. Midbrain-like organoids from human pluripotent stem cells contain functional dopaminergic and neuromelanin-producing neurons. Cell Stem Cell 19, 248\u2013257 (2016).","journal-title":"Cell Stem Cell"},{"key":"1057_CR97","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41586-019-1289-x","volume":"570","author":"S Velasco","year":"2019","unstructured":"Velasco, S. et al. Individual brain organoids reproducibly form cell diversity of the human cerebral cortex. Nature 570, 523\u2013527 (2019).","journal-title":"Nature"},{"key":"1057_CR98","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.stem.2024.11.005","volume":"32","author":"Y Yin","year":"2024","unstructured":"Yin, Y. et al. Generation of self-organized neuromusculoskeletal tri-tissue organoids from human pluripotent stem cells. Cell Stem Cell 32, 157\u2013171.e8 (2024).","journal-title":"Cell Stem Cell"},{"key":"1057_CR99","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1081-0","volume":"9","author":"JH Hor","year":"2018","unstructured":"Hor, J. H. et al. Cell cycle inhibitors protect motor neurons in an organoid model of spinal muscular atrophy. Cell Death Dis. 9, 1100 (2018). This pioneering study established the first human ventral SpCO model derived from NPCs, recapitulating spinal MN identity and identifying aberrant cell cycle re-entry as a therapeutically targetable mechanism in SMA.","journal-title":"Cell Death Dis."},{"key":"1057_CR100","doi-asserted-by":"publisher","first-page":"dev162214","DOI":"10.1242\/dev.162214","volume":"145","author":"T Ogura","year":"2018","unstructured":"Ogura, T., Sakaguchi, H., Miyamoto, S. & Takahashi, J. Three-dimensional induction of dorsal, intermediate and ventral spinal cord tissues from human pluripotent stem cells. Development 145, dev162214 (2018).","journal-title":"Development"},{"key":"1057_CR101","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/s41551-022-00868-4","volume":"6","author":"J-H Lee","year":"2022","unstructured":"Lee, J.-H. et al. Production of human spinal-cord organoids recapitulating neural-tube morphogenesis. Nat. Biomed. Eng. 6, 435\u2013448 (2022). This study generated human SpCOs that recapitulate self-organized neural tube morphogenesis and dorsoventral patterning, establishing a developmentally faithful platform for modelling early human spinal cord development.","journal-title":"Nat. Biomed. Eng."},{"key":"1057_CR102","doi-asserted-by":"publisher","first-page":"dev198275","DOI":"10.1242\/dev.198275","volume":"148","author":"ARG Libby","year":"2021","unstructured":"Libby, A. R. G. et al. Axial elongation of caudalized human organoids mimics aspects of neural tube development. Development 148, dev198275 (2021).","journal-title":"Development"},{"key":"1057_CR103","doi-asserted-by":"publisher","first-page":"dev194514","DOI":"10.1242\/dev.194514","volume":"148","author":"V Mouilleau","year":"2021","unstructured":"Mouilleau, V. et al. Dynamic extrinsic pacing of the HOX clock in human axial progenitors controls motor neuron subtype specification. Development 148, dev194514 (2021). This study generated axially elongated human organoids containing NMP-like populations that recapitulated posterior HOX patterning and caudal identity, representing an early step toward modelling human posterior axis development in vitro.","journal-title":"Development"},{"key":"1057_CR104","doi-asserted-by":"publisher","first-page":"e568","DOI":"10.1002\/cpz1.568","volume":"2","author":"D Whye","year":"2022","unstructured":"Whye, D. et al. Dynamic 3D combinatorial generation of hPSC-derived neuromesodermal organoids with diverse regional and cellular identities. Curr. Protoc. 2, e568 (2022).","journal-title":"Curr. Protoc."},{"key":"1057_CR105","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24776-4","volume":"12","author":"JD Pereira","year":"2021","unstructured":"Pereira, J. D. et al. Human sensorimotor organoids derived from healthy and amyotrophic lateral sclerosis stem cells form neuromuscular junctions. Nat. Commun. 12, 4744 (2021). This pioneering study established the first human ALS sensorimotor organoid model from patient-derived and isogenic iPS cells, enabling mutation-specific interrogation of NMJ dysfunction, impaired muscle contraction and altered innervation within a functionally connected human sensorimotor system.","journal-title":"Nat. Commun."},{"key":"1057_CR106","doi-asserted-by":"publisher","first-page":"eaat5847","DOI":"10.1126\/sciadv.aat5847","volume":"4","author":"T Osaki","year":"2018","unstructured":"Osaki, T., Uzel, S. G. M. & Kamm, R. D. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci. Adv. 4, eaat5847 (2018). This pioneering microfluidic NMJ-on-chip model linked ALS-associated MN pathology to impaired muscle contraction and neurotoxicity, providing one of the first human microphysiological platforms to functionally model neuromuscular degeneration in vitro.","journal-title":"Sci. Adv."},{"key":"1057_CR107","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.cell.2018.09.040","volume":"175","author":"V Metzis","year":"2018","unstructured":"Metzis, V. et al. Nervous system regionalization entails axial allocation before neural differentiation. Cell 175, 1105\u20131118.e17 (2018).","journal-title":"Cell"},{"key":"1057_CR108","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/j.stemcr.2015.02.018","volume":"4","author":"ES Lippmann","year":"2015","unstructured":"Lippmann, E. S. et al. Deterministic HOX patterning in human pluripotent stem cell-derived neuroectoderm. Stem Cell Rep. 4, 632\u2013644 (2015).","journal-title":"Stem Cell Rep."},{"key":"1057_CR109","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.3390\/ijms18102092","volume":"18","author":"V Cappello","year":"2017","unstructured":"Cappello, V. & Francolini, M. Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int. J. Mol. Sci. 18, 2092 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"1057_CR110","doi-asserted-by":"publisher","first-page":"610964","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodriguez Cruz","year":"2020","unstructured":"Rodriguez Cruz, P. M., Cossins, J., Beeson, D. & Vincent, A. The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front. Mol. Neurosci. 13, 610964 (2020).","journal-title":"Front. Mol. Neurosci."},{"key":"1057_CR111","doi-asserted-by":"publisher","first-page":"e2202342","DOI":"10.1002\/adhm.202202342","volume":"12","author":"WH Chooi","year":"2023","unstructured":"Chooi, W. H. et al. Defined alginate hydrogels support spinal cord organoid derivation, maturation, and modeling of spinal cord diseases. Adv. Healthc. Mater. 12, e2202342 (2023).","journal-title":"Adv. Healthc. Mater."},{"key":"1057_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67725-1","volume":"17","author":"I Faravelli","year":"2025","unstructured":"Faravelli, I. et al. Targeted antisense oligonucleotide treatment rescues developmental alterations in spinal muscular atrophy organoids. Nat. Commun. 17, 988 (2025). This study demonstrated that SMA SpCOs exhibit developmental and electrophysiological abnormalities that can be partially rescued by antisense oligonucleotide-mediated SMN restoration.","journal-title":"Nat. Commun."},{"key":"1057_CR113","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3389\/fnmol.2019.00059","volume":"12","author":"HK Shorrock","year":"2019","unstructured":"Shorrock, H. K., Gillingwater, T. H. & Groen, E. J. N. Molecular mechanisms underlying sensory-motor circuit dysfunction in SMA. Front. Mol. Neurosci. 12, 59 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"1057_CR114","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.3390\/biomedicines11112967","volume":"11","author":"S Seki","year":"2023","unstructured":"Seki, S. et al. Characteristics of sensory neuron dysfunction in amyotrophic lateral sclerosis (ALS): potential for ALS therapy. Biomedicines 11, 2967 (2023).","journal-title":"Biomedicines"},{"key":"1057_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-34510-8","volume":"8","author":"SK Vaughan","year":"2018","unstructured":"Vaughan, S. K. et al. The ALS-inducing factors, TDP43A315T and SOD1G93A, directly affect and sensitize sensory neurons to stress. Sci. Rep. 8, 16582 (2018).","journal-title":"Sci. Rep."},{"key":"1057_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11767-8","volume":"12","author":"MA Rubio","year":"2022","unstructured":"Rubio, M. A., Herrando-Grabulosa, M., Gaja-Capdevila, N., Vilches, J. J. & Navarro, X. Characterization of somatosensory neuron involvement in the SOD1G93A mouse model. Sci. Rep. 12, 7600 (2022).","journal-title":"Sci. Rep."},{"key":"1057_CR117","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ana.410380114","volume":"38","author":"JD Rothstein","year":"1995","unstructured":"Rothstein, J. D., Van Kammen, M.,\u00a0Levey, A. I., Martin, L. J. & Kuncl, R. W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38, 73\u201384 (1995).","journal-title":"Ann. Neurol."},{"key":"1057_CR118","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1093\/brain\/awab328","volume":"145","author":"DM Taha","year":"2022","unstructured":"Taha, D. M. et al. Astrocytes display cell autonomous and diverse early reactive states in familial amyotrophic lateral sclerosis. Brain 145, 481\u2013489 (2022).","journal-title":"Brain"},{"key":"1057_CR119","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1172\/JCI90610","volume":"127","author":"T Philips","year":"2017","unstructured":"Philips, T. & Rothstein, J. D. Oligodendroglia: metabolic supporters of neurons. J. Clin. Invest. 127, 3271\u20133280 (2017).","journal-title":"J. Clin. Invest."},{"key":"1057_CR120","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1016\/j.neuron.2020.09.001","volume":"107","author":"G Brancati","year":"2020","unstructured":"Brancati, G., Treutlein, B. & Camp, J. G. Resolving neurodevelopmental and vision disorders using organoid single-cell multi-omics. Neuron 107, 1000\u20131013 (2020).","journal-title":"Neuron"},{"key":"1057_CR121","doi-asserted-by":"publisher","first-page":"4820","DOI":"10.3390\/ijms22094820","volume":"22","author":"V La Cognata","year":"2021","unstructured":"La Cognata, V., Morello, G. & Cavallaro, S. Omics data and their integrative analysis to support stratified medicine in neurodegenerative diseases. Int. J. Mol. Sci. 22, 4820 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1057_CR122","doi-asserted-by":"publisher","first-page":"577755","DOI":"10.3389\/fnins.2020.577755","volume":"14","author":"G Morello","year":"2020","unstructured":"Morello, G., Salomone, S., D\u2019Agata, V., Conforti, F. L. & Cavallaro, S. From multi-omics approaches to precision medicine in amyotrophic lateral sclerosis. Front. Neurosci. 14,\u00a0577755 (2020).","journal-title":"Front. Neurosci."},{"key":"1057_CR123","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1016\/S0140-6736(10)61156-7","volume":"377","author":"MC Kiernan","year":"2011","unstructured":"Kiernan, M. C. et al. Amyotrophic lateral sclerosis. Lancet 377, 942\u2013955 (2011).","journal-title":"Lancet"},{"key":"1057_CR124","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1038\/nrneurol.2014.184","volume":"10","author":"B Swinnen","year":"2014","unstructured":"Swinnen, B. & Robberecht, W. The phenotypic variability of amyotrophic lateral sclerosis. Nat. Rev. Neurol. 10, 661\u2013670 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"1057_CR125","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1002\/neu.10313","volume":"58","author":"S Jablonka","year":"2004","unstructured":"Jablonka, S., Wiese, S. & Sendtner, M. Axonal defects in mouse models of motoneuron disease. J. Neurobiol. 58, 272\u2013286 (2004).","journal-title":"J. Neurobiol."},{"key":"1057_CR126","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1093\/hmg\/ddt222","volume":"22","author":"EJN Groen","year":"2013","unstructured":"Groen, E. J. N. et al. ALS-associated mutations in FUS disrupt the axonal distribution and function of SMN. Hum. Mol. Genet. 22, 3690\u20133704 (2013).","journal-title":"Hum. Mol. Genet."},{"key":"1057_CR127","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1083\/jcb.200303168","volume":"162","author":"ML McWhorter","year":"2003","unstructured":"McWhorter, M. L., Monani, U. R., Burghes, A. H. M. & Beattie, C. E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 162, 919\u2013932 (2003).","journal-title":"J. Cell Biol."},{"key":"1057_CR128","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.stemcr.2021.03.029","volume":"16","author":"K Stoklund Dittlau","year":"2021","unstructured":"Stoklund Dittlau, K. et al. Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep. 16, 2213\u20132227 (2021).","journal-title":"Stem Cell Rep."},{"key":"1057_CR129","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1038\/s42003-021-02538-8","volume":"4","author":"MG Garone","year":"2021","unstructured":"Garone, M. G. et al. ALS-related FUS mutations alter axon growth in motoneurons and affect HuD\/ELAVL4 and FMRP activity. Commun. Biol. 4, 1025 (2021).","journal-title":"Commun. Biol."},{"key":"1057_CR130","doi-asserted-by":"publisher","first-page":"e2148232024","DOI":"10.1523\/JNEUROSCI.2148-23.2024","volume":"44","author":"FW van Tartwijk","year":"2024","unstructured":"van Tartwijk, F. W. et al. Mutation of the ALS-\/FTD-associated RNA-binding protein FUS affects axonal development. J. Neurosci. 44, e2148232024 (2024).","journal-title":"J. Neurosci."},{"key":"1057_CR131","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1002\/jcsm.13094","volume":"13","author":"M Shahriyari","year":"2022","unstructured":"Shahriyari, M. et al. Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy. J. Cachexia Sarcopenia Muscle 13, 3106\u20133121 (2022).","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"1057_CR132","doi-asserted-by":"publisher","first-page":"113133","DOI":"10.1016\/j.yexcr.2022.113133","volume":"416","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y., Torun, T., Maffioletti, S. M., Serio, A. & Tedesco, F. S. Bioengineering human skeletal muscle models: recent advances, current challenges and future perspectives. Exp. Cell Res. 416, 113133 (2022).","journal-title":"Exp. Cell Res."},{"key":"1057_CR133","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1007\/s12035-021-02658-6","volume":"59","author":"S Verma","year":"2022","unstructured":"Verma, S. et al. Neuromuscular junction dysfunction in amyotrophic lateral sclerosis. Mol. Neurobiol. 59, 1502\u20131527 (2022).","journal-title":"Mol. Neurobiol."},{"key":"1057_CR134","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1093\/hmg\/ddn156","volume":"17","author":"S Kariya","year":"2008","unstructured":"Kariya, S. et al. Reduced SMN protein impairs maturation of the neuromuscular junctions in mouse models of spinal muscular atrophy. Hum. Mol. Genet. 17, 2552\u20132569 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"1057_CR135","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40478-022-01360-5","volume":"10","author":"Q Ding","year":"2022","unstructured":"Ding, Q. et al. Impaired signaling for neuromuscular synaptic maintenance is a feature of motor neuron disease. Acta Neuropathol. Commun. 10, 61 (2022).","journal-title":"Acta Neuropathol. Commun."},{"key":"1057_CR136","doi-asserted-by":"publisher","first-page":"113892","DOI":"10.1016\/j.celrep.2024.113892","volume":"43","author":"C Gao","year":"2024","unstructured":"Gao, C. et al. Neuromuscular organoids model spinal neuromuscular pathologies in C9orf72 amyotrophic lateral sclerosis. Cell Rep. 43, 113892 (2024).\u00a0This study established a C9ORF72 neuromuscular organoid platform that models progressive ALS-related neuromuscular pathology, including NMJ degeneration, glial alterations and age-dependent disease phenotypes.","journal-title":"Cell Rep."},{"key":"1057_CR137","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.celrep.2017.11.008","volume":"21","author":"RA Jones","year":"2017","unstructured":"Jones, R. A. et al. Cellular and molecular anatomy of the human neuromuscular junction. Cell Rep. 21, 2348\u20132356 (2017).","journal-title":"Cell Rep."},{"key":"1057_CR138","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1016\/S0140-6736(22)01272-7","volume":"400","author":"EL Feldman","year":"2022","unstructured":"Feldman, E. L. et al. Amyotrophic lateral sclerosis. Lancet 400, 1363\u20131380 (2022).","journal-title":"Lancet"},{"key":"1057_CR139","doi-asserted-by":"publisher","first-page":"613834","DOI":"10.3389\/fneur.2021.613834","volume":"12","author":"G Savini","year":"2021","unstructured":"Savini, G. et al. Pilot study on quantitative cervical cord and muscular MRI in spinal muscular atrophy: promising biomarkers of disease evolution and treatment? Front. Neurol. 12, 613834 (2021).","journal-title":"Front. Neurol."},{"key":"1057_CR140","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1002\/neu.480210208","volume":"21","author":"MK O\u2019Brien","year":"1990","unstructured":"O\u2019Brien, M. K., Landmesser, L. & Oppenheim, R. W. Development and survival of thoracic motoneurons and hindlimb musculature following transplantation of the thoracic neural tube to the lumbar region in the chick embryo: functional aspects. J. Neurobiol. 21, 341\u2013355 (1990).","journal-title":"J. Neurobiol."},{"key":"1057_CR141","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3390\/cells8080906","volume":"8","author":"E Lepore","year":"2019","unstructured":"Lepore, E., Casola, I., Dobrowolny, G. & Musar\u00f2, A. Neuromuscular junction as an entity of nerve-muscle communication. Cells 8, 906 (2019).","journal-title":"Cells"},{"key":"1057_CR142","first-page":"1619","volume":"15","author":"AR Sharma","year":"2024","unstructured":"Sharma, A. R., Chatterjee, S., Lee, Y.-H. & Lee, S.-S. Targeting crosstalk of signaling pathways among muscles-bone-adipose tissue: a promising therapeutic approach for sarcopenia. Aging Dis. 15, 1619\u20131645 (2024).","journal-title":"Aging Dis."},{"key":"1057_CR143","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1002\/jnr.24231","volume":"96","author":"KB Santosa","year":"2018","unstructured":"Santosa, K. B., Keane, A. M., Jablonka-Shariff, A., Vannucci, B. & Snyder-Warwick, A. K. Clinical relevance of terminal Schwann cells: an overlooked component of the neuromuscular junction. J. Neurosci. Res. 96, 1125\u20131135 (2018).","journal-title":"J. Neurosci. Res."},{"key":"1057_CR144","doi-asserted-by":"publisher","first-page":"e12925","DOI":"10.1111\/nan.12925","volume":"49","author":"A Alhindi","year":"2023","unstructured":"Alhindi, A. et al. Neuromuscular junction denervation and terminal Schwann cell loss in the hTDP-43 overexpression mouse model of amyotrophic lateral sclerosis. Neuropathol. Appl. Neurobiol. 49, e12925 (2023).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1057_CR145","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1523\/JNEUROSCI.1379-14.2015","volume":"35","author":"D Arbour","year":"2015","unstructured":"Arbour, D., Tremblay, E., Martineau, E., Julien, J. P. & Robitaille, R. Early and persistent abnormal decoding by glial cells at the neuromuscular junction in an ALS model. J. Neurosci. 35, 688\u2013706 (2015).","journal-title":"J. Neurosci."},{"key":"1057_CR146","doi-asserted-by":"publisher","first-page":"7759","DOI":"10.1523\/JNEUROSCI.1748-18.2020","volume":"40","author":"E Martineau","year":"2020","unstructured":"Martineau, E., Arbour, D., Vallee, J. & Robitaille, R. Properties of glial cell at the neuromuscular junction are incompatible with synaptic repair in the SOD1(G37R) ALS mouse model. J. Neurosci. 40, 7759\u20137777 (2020).","journal-title":"J. Neurosci."},{"key":"1057_CR147","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1634\/stemcells.2005-0076","volume":"24","author":"L Chi","year":"2006","unstructured":"Chi, L. et al. Motor neuron degeneration promotes neural progenitor cell proliferation, migration and neurogenesis in the spinal cords of ALS mice. Stem Cells 24, 34\u201343 (2006).","journal-title":"Stem Cells"},{"key":"1057_CR148","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.stem.2024.03.007","volume":"31","author":"Z Sun","year":"2024","unstructured":"Sun, Z. et al. Harnessing developmental dynamics of spinal cord extracellular matrix improves regenerative potential of spinal cord organoids. Cell Stem Cell 31, 772\u2013787.e11 (2024).","journal-title":"Cell Stem Cell"},{"key":"1057_CR149","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.1021\/acsbiomaterials.4c00029","volume":"10","author":"W Wu","year":"2024","unstructured":"Wu, W. et al. Decellularized brain extracellular matrix hydrogel aids the formation of human spinal-cord organoids recapitulating the complex three-dimensional organization. ACS Biomater. Sci. Eng. 10, 3203\u20133217 (2024).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"1057_CR150","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1002\/sctm.20-0090","volume":"9","author":"P Raffa","year":"2020","unstructured":"Raffa, P. et al. Decellularized skeletal muscles display neurotrophic effects in three-dimensional organotypic cultures. Stem Cells Transl. Med. 9,\u00a01233\u20131243 (2020).","journal-title":"Stem Cells Transl. Med."},{"key":"1057_CR151","doi-asserted-by":"publisher","DOI":"10.1101\/2023.05.19.541464","author":"B Auletta","year":"2023","unstructured":"Auletta, B. et al. Native extracellular matrix promotes human neuromuscular organoid morphogenesis and function. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2023.05.19.541464 (2023).","journal-title":"bioRxiv"},{"key":"1057_CR152","doi-asserted-by":"publisher","first-page":"3218","DOI":"10.1021\/acsbiomaterials.4c00067","volume":"10","author":"Z Wang","year":"2024","unstructured":"Wang, Z. et al. Human placenta decellularized extracellular matrix hydrogel promotes the generation of human spinal cord organoids with dorsoventral organization from human induced pluripotent stem cells. ACS Biomater. Sci. Eng. 10, 3218\u20133231 (2024).","journal-title":"ACS Biomater. Sci. Eng."},{"key":"1057_CR153","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.stemcr.2019.12.005","volume":"14","author":"T Ahfeldt","year":"2020","unstructured":"Ahfeldt, T. et al. Pathogenic pathways in early-onset autosomal recessive Parkinson\u2019s disease discovered using isogenic human dopaminergic neurons. Stem Cell Rep. 14, 75\u201390 (2020).","journal-title":"Stem Cell Rep."},{"key":"1057_CR154","doi-asserted-by":"publisher","first-page":"803","DOI":"10.4252\/wjsc.v11.i10.803","volume":"11","author":"JA Kim","year":"2019","unstructured":"Kim, J. A., Hong, S. & Rhee, W. J. Microfluidic three-dimensional cell culture of stem cells for high-throughput analysis. World J. Stem Cells 11, 803\u2013816 (2019).","journal-title":"World J. Stem Cells"},{"key":"1057_CR155","doi-asserted-by":"publisher","first-page":"311","DOI":"10.7150\/thno.29755","volume":"9","author":"GS Lim","year":"2019","unstructured":"Lim, G. S. et al. Microhexagon gradient array directs spatial diversification of spinal motor neurons. Theranostics 9, 311\u2013323 (2019).","journal-title":"Theranostics"},{"key":"1057_CR156","doi-asserted-by":"publisher","first-page":"2400645","DOI":"10.1002\/admt.202400645","volume":"9","author":"I Kopic","year":"2024","unstructured":"Kopic, I. et al. Inkjet-printed 3D electrode arrays for recording signals from cortical organoids. Adv. Mater. Technol. 9, 2400645 (2024).","journal-title":"Adv. Mater. Technol."},{"key":"1057_CR157","doi-asserted-by":"publisher","first-page":"115223","DOI":"10.1016\/j.bios.2023.115223","volume":"228","author":"M McDonald","year":"2023","unstructured":"McDonald, M. et al. A mesh microelectrode array for non-invasive electrophysiology within neural organoids. Biosens. Bioelectron. 228, 115223 (2023).","journal-title":"Biosens. Bioelectron."},{"key":"1057_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41528-018-0027-z","volume":"2","author":"N Adly","year":"2018","unstructured":"Adly, N. et al. Printed microelectrode arrays on soft materials: from PDMS to hydrogels. NPJ Flex. Electron. 2, 15 (2018).","journal-title":"NPJ Flex. Electron."},{"key":"1057_CR159","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1109\/TBCAS.2015.2468052","volume":"10","author":"J Guo","year":"2016","unstructured":"Guo, J., Ng, W., Yuan, J., Li, S. & Chan, M. A 200-channel area-power-efficient chemical and electrical dual-mode acquisition IC for the study of neurodegenerative diseases. IEEE Trans. Biomed. Circuits Syst. 10, 567\u2013578 (2016).","journal-title":"IEEE Trans. Biomed. Circuits Syst."},{"key":"1057_CR160","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0924-4247(01)00608-2","volume":"91","author":"TD Strong","year":"2001","unstructured":"Strong, T. D., Cantor, H. C. & Brown, R. B. A microelectrode array for real-time neurochemical and neuroelectrical recording in vitro. Sens. Actuators A Phys. 91, 357\u2013362 (2001).","journal-title":"Sens. Actuators A Phys."},{"key":"1057_CR161","doi-asserted-by":"publisher","first-page":"364","DOI":"10.18063\/ijb.v7i3.364","volume":"7","author":"Y Ren","year":"2021","unstructured":"Ren, Y. et al. Developments and opportunities for 3D bioprinted organoids. Int. J. Bioprinting 7, 364 (2021).","journal-title":"Int. J. Bioprinting"},{"key":"1057_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40006-5","volume":"14","author":"JG Roth","year":"2023","unstructured":"Roth, J. G. et al. Spatially controlled construction of assembloids using bioprinting. Nat. Commun. 14, 4346 (2023). This study developed a magnetically guided bioengineering platform enabling high-precision spatial assembly of iPS cell-derived neural organoids with minimal structural deformation, advancing controlled assembloid generation in vitro.","journal-title":"Nat. Commun."},{"key":"1057_CR163","doi-asserted-by":"publisher","first-page":"e44530","DOI":"10.7554\/eLife.44530","volume":"8","author":"M Afshar Bakooshli","year":"2019","unstructured":"Afshar Bakooshli, M. et al. A 3D culture model of innervated human skeletal muscle enables studies of the adult neuromuscular junction. eLife 8, e44530 (2019).","journal-title":"eLife"},{"key":"1057_CR164","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91203-5","volume":"11","author":"RP Rimington","year":"2021","unstructured":"Rimington, R. P., Fleming, J. W., Capel, A. J., Wheeler, P. C. & Lewis, M. P. Bioengineered model of the human motor unit with physiologically functional neuromuscular junctions. Sci. Rep. 11, 11695 (2021).","journal-title":"Sci. Rep."},{"key":"1057_CR165","doi-asserted-by":"publisher","first-page":"101659","DOI":"10.1016\/j.xcrm.2024.101659","volume":"5","author":"T Grass","year":"2024","unstructured":"Grass, T. et al. Isogenic patient-derived organoids reveal early neurodevelopmental defects in spinal muscular atrophy initiation. Cell Rep. Med. 5, 101659 (2024).","journal-title":"Cell Rep. Med."},{"key":"1057_CR166","doi-asserted-by":"publisher","first-page":"103771","DOI":"10.1016\/j.mcn.2022.103771","volume":"123","author":"H Zou","year":"2022","unstructured":"Zou, H. et al. The function of FUS in neurodevelopment revealed by the brain and spinal cord organoids. Mol. Cell. Neurosci. 123, 103771 (2022).","journal-title":"Mol. Cell. Neurosci."},{"key":"1057_CR167","doi-asserted-by":"crossref","unstructured":"P\u00e9rez-Garc\u00eda, M. J., Kong, L., Sumner, C. J. & Tizzano, E. F. in Spinal Muscular Atrophy (eds Sumner, C. J., Paushkin, S. & Ko, C.-P.) 21\u201342 (Academic, 2017).","DOI":"10.1016\/B978-0-12-803685-3.00002-1"},{"key":"1057_CR168","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1093\/hmg\/ddaa146","volume":"29","author":"AAL Motyl","year":"2020","unstructured":"Motyl, A. A. L. et al. Pre-natal manifestation of systemic developmental abnormalities in spinal muscular atrophy. Hum. Mol. Genet. 29, 2674\u20132683 (2020).","journal-title":"Hum. Mol. Genet."},{"key":"1057_CR169","doi-asserted-by":"publisher","first-page":"eabb6871","DOI":"10.1126\/scitranslmed.abb6871","volume":"13","author":"L Kong","year":"2021","unstructured":"Kong, L. et al. Impaired prenatal motor axon development necessitates early therapeutic intervention in severe SMA. Sci. Transl. Med. 13, eabb6871 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1057_CR170","doi-asserted-by":"publisher","first-page":"e13013","DOI":"10.1111\/nan.13013","volume":"50","author":"H Allardyce","year":"2024","unstructured":"Allardyce, H., Lawrence, B. D., Crawford, T. O., Sumner, C. J. & Parson, S. H. A reassessment of spinal cord pathology in severe infantile spinal muscular atrophy: reassessment of spinal cord pathology. Neuropathol. Appl. Neurobiol. 50, e13013 (2024).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"1057_CR171","doi-asserted-by":"publisher","first-page":"eadv4656","DOI":"10.1126\/scitranslmed.adv4656","volume":"17","author":"B Borges","year":"2025","unstructured":"Borges, B. et al. Intra-amniotic antisense oligonucleotide treatment improves phenotypes in preclinical models of spinal muscular atrophy. Sci. Transl. Med. 17, eadv4656 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1057_CR172","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JND-190424","volume":"7","author":"DC Schorling","year":"2020","unstructured":"Schorling, D. C., Pechmann, A. & Kirschner, J. Advances in treatment of spinal muscular atrophy \u2014 new phenotypes, new challenges, new implications for care. J. Neuromuscul. Dis. 7, 1\u201313 (2020).","journal-title":"J. Neuromuscul. Dis."},{"key":"1057_CR173","doi-asserted-by":"publisher","first-page":"3767","DOI":"10.1016\/j.celrep.2017.12.003","volume":"21","author":"CM Simon","year":"2017","unstructured":"Simon, C. M. et al. Converging mechanisms of p53 activation drive motor neuron degeneration in spinal muscular atrophy. Cell Rep. 21, 3767\u20133780 (2017).","journal-title":"Cell Rep."},{"key":"1057_CR174","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3389\/fonc.2018.00608","volume":"8","author":"F Schettini","year":"2018","unstructured":"Schettini, F. et al. CDK 4\/6 inhibitors as single agent in advanced solid tumors. Front. Oncol. 8, 608 (2018).","journal-title":"Front. Oncol."},{"key":"1057_CR175","doi-asserted-by":"publisher","first-page":"dmm050200","DOI":"10.1242\/dmm.050200","volume":"16","author":"Z Ali","year":"2023","unstructured":"Ali, Z. et al. Mutation in the FUS nuclear localisation signal domain causes neurodevelopmental and systemic metabolic alterations. Dis. Model. Mech. 16, dmm050200 (2023).","journal-title":"Dis. Model. Mech."},{"key":"1057_CR176","doi-asserted-by":"publisher","first-page":"689","DOI":"10.2169\/internalmedicine.55.5569","volume":"55","author":"K Hirayanagi","year":"2016","unstructured":"Hirayanagi, K., Sato, M., Furuta, N., Makioka, K. & Ikeda, Y. Juvenile-onset sporadic amyotrophic lateral sclerosis with a frameshift FUS gene mutation presenting unique neuroradiological findings and cognitive impairment. Intern. Med. 55, 689\u2013693 (2016).","journal-title":"Intern. Med."},{"key":"1057_CR177","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S1470-2045(19)30691-6","volume":"21","author":"RC Doebele","year":"2020","unstructured":"Doebele, R. C. et al. Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1\u20132 trials. Lancet. Oncol. 21, 271\u2013282 (2020).","journal-title":"Lancet. Oncol."},{"key":"1057_CR178","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.1007\/s12035-023-03836-4","volume":"61","author":"R Guo","year":"2024","unstructured":"Guo, R. et al. Neural differentiation and spinal cord organoid generation from induced pluripotent stem cells (iPSCs) for ALS modelling and inflammatory screening. Mol. Neurobiol. 61, 4732\u20134749 (2024).","journal-title":"Mol. Neurobiol."},{"key":"1057_CR179","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.3389\/fneur.2018.01167","volume":"9","author":"K Poesen","year":"2019","unstructured":"Poesen, K. & Van Damme, P. Diagnostic and prognostic performance of neurofilaments in ALS. Front. Neurol. 9, 1167 (2019).","journal-title":"Front. Neurol."},{"key":"1057_CR180","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1093\/brain\/awac394","volume":"146","author":"M Benatar","year":"2023","unstructured":"Benatar, M., Wuu, J. & Turner, M. R. Neurofilament light chain in drug development for amyotrophic lateral sclerosis: a critical appraisal. Brain 146, 2711\u20132716 (2023).","journal-title":"Brain"},{"key":"1057_CR181","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1080\/15548627.2021.1926656","volume":"18","author":"JP Chua","year":"2022","unstructured":"Chua, J. P., De Calbiac, H., Kabashi, E. & Barmada, S. J. Autophagy and ALS: mechanistic insights and therapeutic implications. Autophagy 18, 254\u2013282 (2022).","journal-title":"Autophagy"},{"key":"1057_CR182","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1038\/s41593-021-00923-4","volume":"24","author":"K Szeb\u00e9nyi","year":"2021","unstructured":"Szeb\u00e9nyi, K. et al. Human ALS\/FTD brain organoid slice cultures display distinct early astrocyte and targetable neuronal pathology. Nat. Neurosci. 24, 1542\u20131554 (2021).","journal-title":"Nat. Neurosci."},{"key":"1057_CR183","doi-asserted-by":"publisher","first-page":"206ra138","DOI":"10.1126\/scitranslmed.3006767","volume":"5","author":"JA Moreno","year":"2013","unstructured":"Moreno, J. A. et al. Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected mice. Sci. Transl. Med. 5, 206ra138 (2013).","journal-title":"Sci. Transl. Med."},{"key":"1057_CR184","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","volume":"13","author":"R Mejzini","year":"2019","unstructured":"Mejzini, R. et al. ALS genetics, mechanisms, and therapeutics: where are we now? Front. Neurosci. 13, 1310 (2019).","journal-title":"Front. Neurosci."},{"key":"1057_CR185","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s12031-017-0897-x","volume":"61","author":"X Chi","year":"2017","unstructured":"Chi, X. et al. Inhibition of mTOR pathway by rapamycin decreases p-glycoprotein expression and spontaneous seizures in pharmacoresistant epilepsy. J. Mol. Neurosci. 61, 553\u2013562 (2017).","journal-title":"J. Mol. Neurosci."},{"key":"1057_CR186","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1038\/s41587-023-01956-9","volume":"42","author":"S Gribaudo","year":"2024","unstructured":"Gribaudo, S. et al. Self-organizing models of human trunk organogenesis recapitulate spinal cord and spine co-morphogenesis. Nat. Biotechnol. 42, 1243\u20131253 (2024). This study generated elongated self-organizing human trunk-like organoids from iPS cells that recapitulate coordinated neural\u2013mesodermal morphogenesis, anteroposterior axis organization and region-specific neural patterning, closely resembling early human trunk development in vitro.","journal-title":"Nat. Biotechnol."},{"key":"1057_CR187","doi-asserted-by":"publisher","first-page":"105898","DOI":"10.1016\/j.isci.2022.105898","volume":"26","author":"W Xue","year":"2023","unstructured":"Xue, W. et al. Generation of dorsoventral human spinal cord organoids via functionalizing composite scaffold for drug testing. iScience 26, 105898 (2023).","journal-title":"iScience"},{"key":"1057_CR188","doi-asserted-by":"publisher","first-page":"e2301787","DOI":"10.1002\/advs.202301787","volume":"10","author":"K Seo","year":"2023","unstructured":"Seo, K. et al. Symmetry breaking of hPSCs in micropattern generates a polarized spinal cord-like organoid (pSCO) with dorsoventral organization. Adv. Sci. 10, e2301787 (2023).","journal-title":"Adv. Sci."},{"key":"1057_CR189","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cell.2022.12.042","volume":"186","author":"YI Yaman","year":"2023","unstructured":"Yaman, Y. I. & Ramanathan, S. Controlling human organoid symmetry breaking reveals signaling gradients drive segmentation clock waves. Cell 186, 513\u2013527.e9 (2023). This study integrated bioengineering and machine learning strategies to improve organoid reproducibility and spatial organization, generating elongated trunk-like organoids with coordinated neural tube\u2013somite architecture and dorsoventral patterning that closely mimic early human trunk development in vitro.","journal-title":"Cell"},{"key":"1057_CR190","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nrm3448","volume":"13","author":"M Bellin","year":"2012","unstructured":"Bellin, M., Marchetto, M. C., Gage, F. H. & Mummery, C. L. Induced pluripotent stem cells: the new patient? Nat. Rev. Mol. Cell Biol. 13, 713\u2013726 (2012).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"1057_CR191","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.cell.2022.12.043","volume":"186","author":"GM Anand","year":"2023","unstructured":"Anand, G. M. et al. Controlling organoid symmetry breaking uncovers an excitable system underlying human axial elongation. Cell 186, 497\u2013512.e23 (2023).","journal-title":"Cell"},{"key":"1057_CR192","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1038\/s41592-025-02685-4","volume":"22","author":"HT Ong","year":"2025","unstructured":"Ong, H. T. et al. Digitalized organoids: integrated pipeline for high-speed 3D analysis of organoid structures using multilevel segmentation and cellular topology. Nat. Methods 22, 1343\u20131354 (2025).","journal-title":"Nat. Methods"},{"key":"1057_CR193","doi-asserted-by":"publisher","first-page":"100297","DOI":"10.1016\/j.crmeth.2022.100297","volume":"2","author":"JJ Metzger","year":"2022","unstructured":"Metzger, J. J. et al. Deep-learning analysis of micropattern-based organoids enables high-throughput drug screening of Huntington\u2019s disease models. Cell Rep. Methods 2, 100297 (2022).","journal-title":"Cell Rep. Methods"},{"key":"1057_CR194","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67779-1","volume":"17","author":"D Budinger","year":"2026","unstructured":"Budinger, D. et al. An in vivo and in vitro spatiotemporal profile of human midbrain development. Nat. Commun. 17, 1354 (2026).","journal-title":"Nat. Commun."},{"key":"1057_CR195","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/s41586-024-08172-8","volume":"635","author":"Z He","year":"2024","unstructured":"He, Z. et al. An integrated transcriptomic cell atlas of human neural organoids. Nature 635, 690\u2013698 (2024).","journal-title":"Nature"},{"key":"1057_CR196","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/S1474-4422(18)30394-6","volume":"18","author":"DR Beers","year":"2019","unstructured":"Beers, D. R. & Appel, S. H. Immune dysregulation in amyotrophic lateral sclerosis: mechanisms and emerging therapies. Lancet Neurol. 18, 211\u2013220 (2019).","journal-title":"Lancet Neurol."},{"key":"1057_CR197","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/dneu.22905","volume":"82","author":"MJ Wang","year":"2022","unstructured":"Wang, M. J. et al. Microglia in motor neuron disease: signaling evidence from last 10 years. Dev. Neurobiol. 82, 625\u2013638 (2022).","journal-title":"Dev. Neurobiol."},{"key":"1057_CR198","doi-asserted-by":"publisher","first-page":"3526","DOI":"10.1093\/brain\/awaa309","volume":"143","author":"BE Clarke","year":"2020","unstructured":"Clarke, B. E. & Patani, R. The microglial component of amyotrophic lateral sclerosis. Brain 143, 3526\u20133539 (2020).","journal-title":"Brain"},{"key":"1057_CR199","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/jamaneurol.2017.2255","volume":"74","author":"BJ Murdock","year":"2017","unstructured":"Murdock, B. J. et al. Correlation of peripheral immunity with rapid amyotrophic lateral sclerosis progression. JAMA Neurol. 74, 1446\u20131454 (2017).","journal-title":"JAMA Neurol."},{"key":"1057_CR200","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1007\/7651_2024_554","volume":"2951","author":"K Kalpana","year":"2024","unstructured":"Kalpana, K. et al. Generating neuroimmune assembloids using human induced pluripotent stem cell (iPSC)-derived cortical organoids and microglia. Methods Mol. Biol. 2951, 139\u2013158 (2024).","journal-title":"Methods Mol. Biol."},{"key":"1057_CR201","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41531-025-00882-8","volume":"11","author":"E Gerasimova","year":"2025","unstructured":"Gerasimova, E. et al. Novel co-culture model of T cells and midbrain organoids for investigating neurodegeneration in Parkinson\u2019s disease. NPJ Parkinsons Dis. 11, 36 (2025).","journal-title":"NPJ Parkinsons Dis."},{"key":"1057_CR202","doi-asserted-by":"publisher","DOI":"10.1186\/s12938-020-0752-0","volume":"19","author":"Q Wu","year":"2020","unstructured":"Wu, Q. et al. Organ-on-a-chip: recent breakthroughs and future prospects. Biomed. Eng. OnLine 19, 9 (2020).","journal-title":"Biomed. Eng. OnLine"},{"key":"1057_CR203","doi-asserted-by":"publisher","first-page":"e3000705","DOI":"10.1371\/journal.pbio.3000705","volume":"18","author":"Y Shi","year":"2020","unstructured":"Shi, Y. et al. Vascularized human cortical organoids (vOrganoids) model cortical development in vivo. PLoS Biol. 18, e3000705 (2020).","journal-title":"PLoS Biol."},{"key":"1057_CR204","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52204-7","volume":"9","author":"P W\u00f6rsd\u00f6rfer","year":"2019","unstructured":"W\u00f6rsd\u00f6rfer, P. et al. Generation of complex human organoid models including vascular networks by incorporation of mesodermal progenitor cells. Sci. Rep. 9, 15663 (2019).","journal-title":"Sci. Rep."},{"key":"1057_CR205","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nprot.2017.152","volume":"13","author":"X Qian","year":"2018","unstructured":"Qian, X. et al. Generation of human brain region-specific organoids using a miniaturized spinning bioreactor. Nat. Protoc. 13, 565\u2013580 (2018).","journal-title":"Nat. Protoc."},{"key":"1057_CR206","doi-asserted-by":"publisher","DOI":"10.1101\/2025.10.01.679721","author":"I Faravelli","year":"2025","unstructured":"Faravelli, I. et al. Human brain organoids record the passage of time over multiple years in culture. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.10.01.679721 (2025).","journal-title":"bioRxiv"},{"key":"1057_CR207","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.cell.2022.11.001","volume":"186","author":"C Lopez-Otin","year":"2023","unstructured":"Lopez-Otin, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. Hallmarks of aging: an expanding universe. Cell 186, 243\u2013278 (2023).","journal-title":"Cell"},{"key":"1057_CR208","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12979-025-00530-y","volume":"22","author":"A Kamroo","year":"2025","unstructured":"Kamroo, A. et al. Immunosenescence and organoids: pathophysiology and therapeutic opportunities. Immun. Ageing 22, 46 (2025).","journal-title":"Immun. Ageing"},{"key":"1057_CR209","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s10522-023-10076-5","volume":"25","author":"J Harley","year":"2024","unstructured":"Harley, J. et al. Telomere shortening induces aging-associated phenotypes in hiPSC-derived neurons and astrocytes. Biogerontology 25, 341\u2013360 (2024).","journal-title":"Biogerontology"},{"key":"1057_CR210","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.stem.2013.11.006","volume":"13","author":"JD Miller","year":"2013","unstructured":"Miller, J. D. et al. Human iPSC-based modeling of late-onset disease via progerin-induced aging. Cell Stem Cell 13, 691\u2013705 (2013).","journal-title":"Cell Stem Cell"},{"key":"1057_CR211","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-46004-5","volume":"15","author":"PR Pitrez","year":"2024","unstructured":"Pitrez, P. R. et al. Cellular reprogramming as a tool to model human aging in a dish. Nat. Commun. 15, 1816 (2024).","journal-title":"Nat. Commun."},{"key":"1057_CR212","doi-asserted-by":"publisher","first-page":"dmm.042317","DOI":"10.1242\/dmm.042317","volume":"13","author":"V Volpato","year":"2020","unstructured":"Volpato, V. & Webber, C. Addressing variability in iPSC-derived models of human disease: guidelines to promote reproducibility. Dis. Model. Mech. 13, dmm.042317 (2020).","journal-title":"Dis. Model. Mech."},{"key":"1057_CR213","doi-asserted-by":"publisher","unstructured":"Scuderi, S. et al. Specification of human regional brain lineages using orthogonal gradients of WNT and SHH in organoids. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2024.05.18.594828 (2024).","DOI":"10.1101\/2024.05.18.594828"},{"key":"1057_CR214","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s00401-017-1708-8","volume":"133","author":"J Nijssen","year":"2017","unstructured":"Nijssen, J., Comley, L. H. & Hedlund, E. Motor neuron vulnerability and resistance in amyotrophic lateral sclerosis. Acta Neuropathol. 133, 863\u2013885 (2017).","journal-title":"Acta Neuropathol."},{"key":"1057_CR215","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1039\/C4LC01253D","volume":"15","author":"H Song","year":"2015","unstructured":"Song, H. et al. Continuous-flow sorting of stem cells and differentiation products based on dielectrophoresis. Lab. Chip 15, 1320\u20131328 (2015).","journal-title":"Lab. Chip"},{"key":"1057_CR216","doi-asserted-by":"publisher","DOI":"10.1038\/srep38856","volume":"6","author":"NR Wevers","year":"2016","unstructured":"Wevers, N. R. et al. High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform. Sci. Rep. 6, 38856 (2016).","journal-title":"Sci. Rep."},{"key":"1057_CR217","doi-asserted-by":"publisher","first-page":"2604","DOI":"10.1039\/C8LC00525G","volume":"18","author":"YJ Yu","year":"2018","unstructured":"Yu, Y. J. et al. Hydrogel-incorporating unit in a well: 3D cell culture for high-throughput analysis. Lab. Chip 18, 2604\u20132613 (2018).","journal-title":"Lab. Chip"},{"key":"1057_CR218","doi-asserted-by":"publisher","first-page":"e52904","DOI":"10.7554\/eLife.52904","volume":"9","author":"H Renner","year":"2020","unstructured":"Renner, H. et al. A fully automated high-throughput workflow for 3D-based chemical screening in human midbrain organoids. eLife 9, e52904 (2020).","journal-title":"eLife"},{"key":"1057_CR219","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s44385-025-00054-6","volume":"3","author":"D Kim","year":"2026","unstructured":"Kim, D. et al. From organoid culture to manufacturing: technologies for reproducible and scalable organoid production. NPJ Biomed. Innov. 3, 12 (2026).","journal-title":"NPJ Biomed. Innov."},{"key":"1057_CR220","doi-asserted-by":"publisher","first-page":"204173142513194","DOI":"10.1177\/20417314251319475","volume":"16","author":"X Fan","year":"2025","unstructured":"Fan, X. et al. Strategies to overcome the limitations of current organoid technology \u2014 engineered organoids. J. Tissue Eng. 16, 20417314251319475 (2025).","journal-title":"J. Tissue Eng."},{"key":"1057_CR221","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3390\/cells14060421","volume":"14","author":"S Bond","year":"2025","unstructured":"Bond, S., Saxena, S. & Sierra-Delgado, J. A. Microglia in ALS: insights into mechanisms and therapeutic potential. Cells 14, 421 (2025).","journal-title":"Cells"},{"key":"1057_CR222","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/s41593-025-02075-1","volume":"28","author":"P Masrori","year":"2025","unstructured":"Masrori, P. et al. C9orf72 hexanucleotide repeat expansions impair microglial response in ALS. Nat. Neurosci. 28, 2217\u20132230 (2025).","journal-title":"Nat. Neurosci."},{"key":"1057_CR223","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35494-w","volume":"14","author":"J Eshima","year":"2023","unstructured":"Eshima, J. et al. Molecular subtypes of ALS are associated with differences in patient prognosis. Nat. Commun. 14, 95 (2023).","journal-title":"Nat. Commun."},{"key":"1057_CR224","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00401-012-1039-8","volume":"125","author":"EA Winkler","year":"2013","unstructured":"Winkler, E. A. et al. Blood-spinal cord barrier breakdown and pericyte reductions in amyotrophic lateral sclerosis. Acta Neuropathol. 125, 111\u2013120 (2013).","journal-title":"Acta Neuropathol."},{"key":"1057_CR225","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/brain\/awaf392","volume":"149","author":"L Ottoboni","year":"2026","unstructured":"Ottoboni, L., Bruno, C. & Corti, S. Decoding inflammatory pathways in spinal muscular atrophy: implications for next-generation therapies. Brain 149, 404\u2013421 (2026).","journal-title":"Brain"}],"container-title":["Nature Reviews Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01057-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01057-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T12:02:39Z","timestamp":1787054559000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41583-026-01057-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":225,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1057"],"URL":"https:\/\/doi.org\/10.1038\/s41583-026-01057-x","relation":{},"ISSN":["1471-003X","1471-0048"],"issn-type":[{"value":"1471-003X","type":"print"},{"value":"1471-0048","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"3 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.V.D.B. is head of the Scientific Advisory Board of Augustine Therapeutics (Leuven, Belgium) and is part of the Investment Advisory Board of Droia Ventures (Meise, Belgium). The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}